Drug Trial Radar · NCT00101751
INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study
Last checked: Nov 19, 2026Latest source record: Nov 2, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,877
Actual
Start
Oct 2004
Primary completion
Jun 2006
Study completion Jun 2006
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Jan 13, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is conducted in the United States of America (USA). The purpose of this study is to compare the effectiveness and safety of a biphasic insulin aspart standard titration regimen when coupled with dietary intervention to standard titration without dietary intervention.
Conditions
- Diabetes
- Diabetes Mellitus, Type 2
Interventions
biphasic insulin aspartDrug
dietary regimenBehavioral
Primary outcomes
What the sponsor says the trial is designed to measure.
- HbA1c and Incidence of hypoglycemiaTime frame: After 24 weeks of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Novo Nordisk Clinical Trial Call Center
Princeton, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.